Souhaitez-vous accéder aux communiqués récents ?

Aardvark Therapeutics Announces Leadership Appointments

Aarhus, Denmark, 12 February 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data...

Agios (Nasdaq: AGIO) announces financial results and updates for the fourth quarter and year ended December 31, 2025.

Aarhus, Denmark, 12 February 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data...

CORAL GABLES, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...

BOOST Pharma announces the appointment of seasoned biotech entrepreneur Hans Schambye, MD, PhD, as its new Chief Executive Officer.

FRISCO, Texas and CHESTERFIELD, Mo., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the...

Philanthropic funding from the FA Alliance Innovation Fund was awarded to five Oxford researchers to support the development of novel therapeutics

Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both treatment-naïve individuals and those previously treated with 12 mg nusinersenThe...

Washington, D.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today applauded the bipartisan passage of the annual federal funding bill that sustains critical...